| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.79 | 0.006 | 0.79 | Analgesic | 0.383 0.092 CID_154700035 | ||
| 0.79 | 0.018 | 0.812 | Apoptosis agonist | 0.812 0.015 CID_154700035 | CID_154700035 | |
| 0.687 | 0.033 | 0.862 | Antiinflammatory | 0.862 0.008 CID_154700035 | CID_154700035 | |
| 0.643 | 0.008 | 0.747 | Nitric oxide antagonist | 0.747 0.005 CID_154700035 | CID_154700035 | |
| 0.619 | 0.034 | 0.651 | Caspase 9 stimulant | 0.651 0.03 CID_154700035 | CID_154700035 | |
| 0.553 | 0.02 | 0.595 | Immunosuppressant | 0.595 0.014 CID_154700035 | CID_154700035 | |
| 0.538 | 0.015 | 0.538 | Nootropic | 0.205 0.151 CID_154700035 | ||
| 0.543 | 0.026 | 0.716 | Cholesterol antagonist | 0.716 0.007 CID_154700035 | CID_154700035 | |
| 0.536 | 0.028 | 0.536 | Aldehyde oxidase inhibitor | |||
| 0.467 | 0.007 | 0.467 | Cholinergic | |||
| 0.458 | 0.005 | 0.458 | Acetylcholinesterase inhibitor | 0.129 0.07 CID_154700035 | ||
| 0.469 | 0.049 | 0.727 | Transcription factor NF kappa B inhibitor | 0.727 0.018 CID_154700035 | CID_154700035 | |
| 0.431 | 0.022 | 0.537 | Tumour necrosis factor alpha release inhibitor | 0.537 0.011 CID_154700035 | CID_154700035 | |
| 0.385 | 0.01 | 0.385 | Lipocortins synthesis antagonist | 0.295 0.022 CID_154700035 | ||
| 0.382 | 0.023 | 0.382 | Sodium/bile acid cotransporter inhibitor | 0.317 0.065 CID_154700035 | ||
| 0.388 | 0.048 | 0.388 | 5 Hydroxytryptamine release stimulant | 0.357 0.055 CID_154700035 | ||
| 0.358 | 0.023 | 0.38 | RNA-directed DNA polymerase inhibitor | 0.38 0.02 CID_154700035 | CID_154700035 | |
| 0.38 | 0.071 | 0.38 | GABA C receptor rho-3 antagonist | |||
| 0.352 | 0.048 | 0.352 | Calcium channel activator | |||
| 0.321 | 0.029 | 0.346 | Anesthetic general | 0.346 0.024 CID_154700035 | CID_154700035 | |
| 0.295 | 0.005 | 0.295 | Opioid kappa receptor antagonist | |||
| 0.339 | 0.049 | 0.699 | Antioxidant | 0.699 0.006 CID_154700035 | CID_154700035 | |
| 0.307 | 0.019 | 0.454 | Interferon gamma antagonist | 0.454 0.008 CID_154700035 | CID_154700035 | |
| 0.312 | 0.03 | 0.312 | Growth hormone agonist | |||
| 0.321 | 0.048 | 0.321 | Cardiotonic | |||
| 0.368 | 0.101 | 0.445 | 5 Hydroxytryptamine release inhibitor | 0.445 0.054 CID_154700035 | CID_154700035 | |
| 0.305 | 0.043 | 0.305 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.255 | 0.004 | 0.255 | Adenylate cyclase stimulant | 0.19 0.019 CID_154700035 | ||
| 0.272 | 0.021 | 0.272 | Bone formation stimulant | 0.182 0.041 CID_154700035 | ||
| 0.263 | 0.013 | 0.483 | Antineoplastic antibiotic | 0.483 0.004 CID_154700035 | CID_154700035 | |
| 0.285 | 0.041 | 0.285 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.266 | 0.023 | 0.37 | Protein kinase stimulant | 0.37 0.01 CID_154700035 | CID_154700035 | |
| 0.258 | 0.022 | 0.429 | Alpha-N-acetylglucosaminidase inhibitor | 0.429 0.008 CID_154700035 | CID_154700035 | |
| 0.241 | 0.008 | 0.241 | Arachidonic acid antagonist | 0.205 0.028 CID_154700035 | ||
| 0.258 | 0.034 | 0.269 | Neurotrophic factor enhancer | 0.269 0.029 CID_154700035 | CID_154700035 | |
| 0.275 | 0.053 | 0.417 | DNA synthesis inhibitor | 0.417 0.02 CID_154700035 | CID_154700035 | |
| 0.217 | 0.009 | 0.217 | Antineoplastic alkaloid | |||
| 0.238 | 0.031 | 0.376 | Melanin inhibitor | 0.376 0.014 CID_154700035 | CID_154700035 | |
| 0.22 | 0.016 | 0.245 | Microtubule formation inhibitor | 0.245 0.01 CID_154700035 | CID_154700035 | |
| 0.199 | 0.005 | 0.199 | Opioid kappa receptor agonist | 0.051 0.023 CID_154700035 | ||
| 0.223 | 0.03 | 0.223 | Interleukin 6 antagonist | 0.223 0.03 CID_154700035 | ||
| 0.221 | 0.035 | 0.221 | Succinate dehydrogenase inhibitor | |||
| 0.193 | 0.013 | 0.193 | Pregnane X receptor agonist | |||
| 0.191 | 0.015 | 0.191 | GABA C receptor antagonist | |||
| 0.202 | 0.026 | 0.202 | Cholesterol synthesis inhibitor | 0.16 0.04 CID_154700035 | ||
| 0.183 | 0.007 | 0.183 | Anabolic | 0.143 0.022 CID_154700035 | ||
| 0.197 | 0.021 | 0.197 | GABA C receptor agonist | |||
| 0.251 | 0.078 | 0.415 | Interleukin agonist | 0.415 0.017 CID_154700035 | CID_154700035 | |
| 0.338 | 0.165 | 0.338 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.181 | 0.009 | 0.192 | Toll-Like receptor 4 antagonist | 0.192 0.007 CID_154700035 | CID_154700035 | |
| 0.178 | 0.008 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.169 0.014 CID_154700035 | ||
| 0.184 | 0.017 | 0.184 | Opioid antagonist | |||
| 0.193 | 0.027 | 0.193 | Adenylate cyclase inhibitor | 0.135 0.056 CID_154700035 | ||
| 0.216 | 0.056 | 0.504 | Hepatoprotectant | 0.504 0.007 CID_154700035 | CID_154700035 | |
| 0.217 | 0.06 | 0.217 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.174 0.101 CID_154700035 | ||
| 0.243 | 0.087 | 0.243 | Gastrin inhibitor | 0.185 0.171 CID_154700035 | ||
| 0.258 | 0.105 | 0.316 | Caspase 3 stimulant | 0.316 0.071 CID_154700035 | CID_154700035 | |
| 0.179 | 0.028 | 0.368 | Cyclooxygenase 3 inhibitor | 0.368 0.004 CID_154700035 | CID_154700035 | |
| 0.181 | 0.036 | 0.181 | CF transmembrane conductance regulator agonist | 0.129 0.12 CID_154700035 | ||
| 0.226 | 0.082 | 0.748 | Angiogenesis stimulant | 0.748 0.004 CID_154700035 | CID_154700035 | |
| 0.159 | 0.015 | 0.159 | Opioid mu receptor antagonist | |||
| 0.143 | 0.007 | 0.143 | Oxytocin antagonist | |||
| 0.14 | 0.006 | 0.14 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.142 | 0.009 | 0.154 | Glycine receptor antagonist | 0.154 0.007 CID_154700035 | CID_154700035 | |
| 0.148 | 0.016 | 0.201 | Transcription factor NF kappa B stimulant | 0.201 0.009 CID_154700035 | CID_154700035 | |
| 0.138 | 0.009 | 0.138 | Glycine receptor agonist | 0.113 0.015 CID_154700035 | ||
| 0.144 | 0.015 | 0.144 | Keratolytic | |||
| 0.136 | 0.009 | 0.153 | Na+ K+ transporting ATPase inhibitor | 0.153 0.005 CID_154700035 | CID_154700035 | |
| 0.147 | 0.023 | 0.147 | Androgen antagonist | |||
| 0.135 | 0.012 | 0.135 | Estrogen agonist | 0.085 0.021 CID_154700035 | ||
| 0.147 | 0.026 | 0.168 | CC chemokine 6 receptor antagonist | 0.168 0.008 CID_154700035 | CID_154700035 | |
| 0.234 | 0.116 | 0.239 | Hypoxia-inducible factor 1 alpha inhibitor | 0.239 0.111 CID_154700035 | CID_154700035 | |
| 0.136 | 0.022 | 0.136 | Opioid delta receptor antagonist | |||
| 0.132 | 0.021 | 0.132 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.22 | 0.111 | 0.22 | Transcription factor STAT3 inhibitor | |||
| 0.135 | 0.025 | 0.273 | Triose-phosphate isomerase inhibitor | 0.273 0.005 CID_154700035 | CID_154700035 | |
| 0.14 | 0.033 | 0.355 | UDP-glucose 4-epimerase inhibitor | 0.355 0.008 CID_154700035 | CID_154700035 | |
| 0.123 | 0.017 | 0.123 | Vanilloid agonist | |||
| 0.11 | 0.004 | 0.11 | Adenylate cyclase 1 inhibitor | |||
| 0.238 | 0.133 | 0.453 | Interleukin 2 agonist | 0.453 0.015 CID_154700035 | CID_154700035 | |
| 0.173 | 0.069 | 0.173 | Phospholipase C inhibitor | 0.165 0.08 CID_154700035 | ||
| 0.108 | 0.003 | 0.108 | Progesterone agonist | 0.026 0.008 CID_154700035 | ||
| 0.209 | 0.108 | 0.209 | Superoxide dismutase inhibitor | |||
| 0.123 | 0.024 | 0.245 | Phosphofructokinase-1 inhibitor | 0.245 0.008 CID_154700035 | CID_154700035 | |
| 0.179 | 0.081 | 0.179 | P-glycoprotein inhibitor | 0.155 0.11 CID_154700035 | ||
| 0.105 | 0.007 | 0.105 | Potassium channel Kv1.3 blocker | |||
| 0.105 | 0.008 | 0.105 | Estrogen receptor alpha agonist | |||
| 0.108 | 0.012 | 0.108 | Opioid mu receptor agonist | |||
| 0.102 | 0.007 | 0.102 | Heme oxygenase stimulant | 0.068 0.029 CID_154700035 | ||
| 0.118 | 0.023 | 0.118 | Analgesic, opioid | |||
| 0.104 | 0.012 | 0.104 | Opioid agonist | |||
| 0.202 | 0.11 | 0.735 | Hypoglycemic | 0.735 0.005 CID_154700035 | CID_154700035 | |
| 0.101 | 0.01 | 0.101 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.104 | 0.013 | 0.104 | Androgen agonist | |||
| 0.129 | 0.039 | 0.129 | Estrogen antagonist | |||
| 0.162 | 0.072 | 0.162 | Peroxidase inhibitor | |||
| 0.099 | 0.011 | 0.099 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.204 | 0.118 | 0.47 | Immunostimulant | 0.47 0.033 CID_154700035 | CID_154700035 | |
| 0.125 | 0.04 | 0.125 | DOPA decarboxylase inhibitor | |||
| 0.095 | 0.012 | 0.095 | Estrogen receptor beta agonist | 0.036 0.022 CID_154700035 | ||
| 0.116 | 0.034 | 0.116 | ABCA1 expression enhancer | |||
| 0.137 | 0.057 | 0.196 | DNA polymerase I inhibitor | 0.196 0.029 CID_154700035 | CID_154700035 | |
| 0.085 | 0.005 | 0.085 | Pregnane X receptor antagonist | |||
| 0.088 | 0.007 | 0.088 | Vasopressin 2 antagonist | |||
| 0.141 | 0.064 | 0.141 | Farnesoid X receptor antagonist | |||
| 0.174 | 0.097 | 0.174 | Psychostimulant | 0.174 0.097 CID_154700035 | ||
| 0.109 | 0.032 | 0.109 | Porphobilinogen synthase inhibitor | |||
| 0.11 | 0.034 | 0.11 | Ornithine decarboxylase inhibitor | 0.076 0.072 CID_154700035 | ||
| 0.096 | 0.02 | 0.096 | Vanilloid 4 agonist | |||
| 0.083 | 0.008 | 0.083 | RNA-directed RNA polymerase stimulant | 0.045 0.015 CID_154700035 | ||
| 0.125 | 0.05 | 0.125 | Ferrochelatase inhibitor | |||
| 0.114 | 0.04 | 0.114 | Estrogen receptor beta antagonist | |||
| 0.225 | 0.152 | 0.437 | Apoptosis antagonist | 0.437 0.03 CID_154700035 | CID_154700035 | |
| 0.084 | 0.011 | 0.088 | Lipocortins synthesis agonist | 0.088 0.009 CID_154700035 | CID_154700035 | |
| 0.116 | 0.044 | 0.116 | Creatine kinase inhibitor | |||
| 0.094 | 0.023 | 0.094 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.098 | 0.027 | 0.098 | Estrogen-related receptor beta agonist | |||
| 0.075 | 0.005 | 0.075 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.117 | 0.046 | 0.117 | Adenylate kinase inhibitor | 0.095 0.076 CID_154700035 | ||
| 0.09 | 0.021 | 0.09 | Alcohol oxidase inhibitor | |||
| 0.132 | 0.062 | 0.132 | Vanilloid 1 agonist | 0.113 0.106 CID_154700035 | ||
| 0.1 | 0.031 | 0.1 | Glutamate dehydrogenase inhibitor | |||
| 0.235 | 0.167 | 0.479 | Histamine release inhibitor | 0.479 0.037 CID_154700035 | CID_154700035 | |
| 0.157 | 0.09 | 0.248 | ATPase inhibitor | 0.248 0.014 CID_154700035 | CID_154700035 | |
| 0.178 | 0.113 | 0.288 | Cyclic AMP phosphodiesterase inhibitor | 0.288 0.047 CID_154700035 | CID_154700035 | |
| 0.076 | 0.012 | 0.076 | Ryanodine receptor antagonist | |||
| 0.104 | 0.04 | 0.203 | NADH dehydrogenase inhibitor | 0.203 0.01 CID_154700035 | CID_154700035 | |
| 0.069 | 0.007 | 0.069 | Microtubule stabilization | 0.063 0.011 CID_154700035 | ||
| 0.152 | 0.092 | 0.152 | Antipruritic | |||
| 0.067 | 0.008 | 0.067 | GABA uptake inhibitor | |||
| 0.082 | 0.024 | 0.082 | Argininosuccinate synthase inhibitor | 0.053 0.043 CID_154700035 | ||
| 0.258 | 0.203 | 0.798 | Cyclophilin D inhibitor | 0.798 0.007 CID_154700035 | CID_154700035 | |
| 0.064 | 0.01 | 0.064 | Vasopressin 1A antagonist | |||
| 0.089 | 0.036 | 0.089 | Estrogen receptor alpha antagonist | |||
| 0.079 | 0.028 | 0.079 | Aromatase inhibitor | |||
| 0.065 | 0.015 | 0.096 | Glucose-6-phosphate isomerase inhibitor | 0.096 0.005 CID_154700035 | CID_154700035 | |
| 0.068 | 0.019 | 0.068 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.102 | 0.053 | 0.102 | Prolactin inhibitor | |||
| 0.064 | 0.017 | 0.064 | Aldosterone antagonist | |||
| 0.163 | 0.116 | 0.163 | Insulin sensitizer | |||
| 0.054 | 0.007 | 0.054 | Tubulin agonist | 0.04 0.015 CID_154700035 | ||
| 0.111 | 0.064 | 0.111 | Acetylcholine release stimulant | 0.1 0.087 CID_154700035 | ||
| 0.21 | 0.164 | 0.219 | Vasodilator, peripheral | 0.219 0.155 CID_154700035 | CID_154700035 | |
| 0.135 | 0.089 | 0.135 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.107 | 0.061 | 0.306 | Expectorant | 0.306 0.008 CID_154700035 | CID_154700035 | |
| 0.084 | 0.039 | 0.084 | CDC25A inhibitor | |||
| 0.074 | 0.029 | 0.074 | Purinergic P2X1 antagonist | |||
| 0.095 | 0.051 | 0.116 | Glutamate release inhibitor | 0.116 0.025 CID_154700035 | CID_154700035 | |
| 0.048 | 0.004 | 0.048 | Purinergic P2Y1 antagonist | |||
| 0.052 | 0.008 | 0.052 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.041 0.011 CID_154700035 | ||
| 0.126 | 0.083 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.098 | 0.056 | 0.143 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.143 0.029 CID_154700035 | CID_154700035 | |
| 0.097 | 0.056 | 0.097 | Bile acid receptor antagonist | |||
| 0.074 | 0.033 | 0.074 | Glutamate (mGluR6) antagonist | |||
| 0.165 | 0.125 | 0.165 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.191 | 0.152 | 0.191 | Transcription factor STAT inhibitor | |||
| 0.107 | 0.068 | 0.144 | Mucolytic | 0.144 0.036 CID_154700035 | CID_154700035 | |
| 0.11 | 0.071 | 0.11 | TRPA1 agonist | |||
| 0.169 | 0.132 | 0.534 | Vasodilator | 0.534 0.009 CID_154700035 | CID_154700035 | |
| 0.175 | 0.139 | 0.18 | Nitric-oxide synthase stimulant | 0.18 0.127 CID_154700035 | CID_154700035 | |
| 0.108 | 0.074 | 0.148 | Photosensitizer | 0.148 0.032 CID_154700035 | CID_154700035 | |
| 0.047 | 0.013 | 0.047 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.051 | 0.017 | 0.051 | Retinoid X receptor agonist | |||
| 0.164 | 0.131 | 0.432 | Platelet antagonist | 0.432 0.022 CID_154700035 | CID_154700035 | |
| 0.035 | 0.002 | 0.056 | Telomerase stimulant | 0.056 0.001 CID_154700035 | CID_154700035 | |
| 0.132 | 0.101 | 0.132 | GABA C receptor rho-2 antagonist | |||
| 0.077 | 0.047 | 0.077 | Glutamate decarboxylase inhibitor | |||
| 0.035 | 0.006 | 0.035 | Vitamin D receptor antagonist | 0.028 0.008 CID_154700035 | ||
| 0.103 | 0.074 | 0.103 | Cystathionine beta-synthase inhibitor | |||
| 0.05 | 0.021 | 0.06 | Guanylate cyclase inhibitor | 0.06 0.011 CID_154700035 | CID_154700035 | |
| 0.058 | 0.029 | 0.107 | Alpha-mannosidase inhibitor | 0.107 0.005 CID_154700035 | CID_154700035 | |
| 0.034 | 0.007 | 0.034 | Hedgehog signaling activator | |||
| 0.04 | 0.013 | 0.04 | ATP citrate lysase inhibitor | |||
| 0.046 | 0.02 | 0.046 | Progesterone antagonist | |||
| 0.059 | 0.034 | 0.059 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.044 | 0.019 | 0.044 | Retinoic acid alpha receptor agonist | |||
| 0.042 | 0.018 | 0.042 | Glucocorticoid antagonist | |||
| 0.055 | 0.031 | 0.055 | Aconitate hydratase inhibitor | |||
| 0.087 | 0.064 | 0.087 | Potassium channel activator | |||
| 0.047 | 0.026 | 0.047 | Parathyroid hormone antagonist | |||
| 0.042 | 0.021 | 0.042 | Farnesoid X receptor agonist | |||
| 0.04 | 0.02 | 0.04 | Retinoid X alpha receptor agonist | |||
| 0.038 | 0.018 | 0.038 | Vasopressin 1 antagonist | |||
| 0.167 | 0.148 | 0.256 | DNA damaging | 0.256 0.077 CID_154700035 | CID_154700035 | |
| 0.043 | 0.025 | 0.043 | Kainate receptor agonist | |||
| 0.021 | 0.004 | 0.023 | Antibiotic Tetracycline-like | 0.023 0.003 CID_154700035 | CID_154700035 | |
| 0.063 | 0.047 | 0.063 | Transcription factor RelA inhibitor | |||
| 0.091 | 0.076 | 0.091 | GABA C receptor rho-1 antagonist | |||
| 0.115 | 0.099 | 0.28 | Lipid peroxidase inhibitor | 0.28 0.022 CID_154700035 | CID_154700035 | |
| 0.062 | 0.048 | 0.065 | Interferon inducer | 0.065 0.042 CID_154700035 | CID_154700035 | |
| 0.027 | 0.012 | 0.027 | Retinoid X gamma receptor agonist | |||
| 0.039 | 0.025 | 0.039 | 5-Alpha-reductase inhibitor | |||
| 0.028 | 0.015 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.072 | 0.059 | 0.075 | GABA aminotransferase inhibitor | 0.075 0.054 CID_154700035 | CID_154700035 | |
| 0.104 | 0.091 | 0.104 | Aldehyde dehydrogenase inhibitor | |||
| 0.08 | 0.067 | 0.08 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.024 | 0.011 | 0.028 | Corticosteroid-like | 0.028 0.008 CID_154700035 | CID_154700035 | |
| 0.022 | 0.01 | 0.022 | Retinoid X beta receptor antagonist | |||
| 0.039 | 0.027 | 0.039 | Membrane dipeptidase inhibitor | |||
| 0.026 | 0.014 | 0.026 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.028 | 0.016 | 0.028 | Nicotinic acid receptor 2 antagonist | |||
| 0.038 | 0.027 | 0.038 | Retinoid X receptor antagonist | |||
| 0.056 | 0.045 | 0.056 | Botulinum neurotoxin type A inhibitor | |||
| 0.028 | 0.017 | 0.028 | Retinoid X gamma receptor antagonist | |||
| 0.074 | 0.063 | 0.078 | Interferon agonist | 0.078 0.055 CID_154700035 | CID_154700035 | |
| 0.166 | 0.155 | 0.403 | Peptidyltransferase inhibitor | 0.403 0.007 CID_154700035 | CID_154700035 | |
| 0.023 | 0.014 | 0.023 | Estrone sulfatase inhibitor | |||
| 0.033 | 0.025 | 0.033 | Retinoid X alpha receptor antagonist | |||
| 0.023 | 0.014 | 0.023 | Retinoic acid gamma receptor agonist | |||
| 0.021 | 0.013 | 0.021 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.036 | 0.03 | 0.036 | Antidiuretic hormone antagonist | |||
| 0.021 | 0.015 | 0.021 | Retinoid X beta receptor agonist | |||
| 0.019 | 0.013 | 0.037 | Antibiotic Anthracycline-like | 0.037 0.003 CID_154700035 | CID_154700035 | |
| 0.013 | 0.008 | 0.013 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.032 | 0.027 | 0.032 | Fumarate hydratase inhibitor | |||
| 0.007 | 0.003 | 0.007 | Transcortin receptor antagonist | |||
| 0.1 | 0.097 | 0.33 | Amylase inhibitor | 0.33 0.015 CID_154700035 | CID_154700035 | |
| 0.035 | 0.032 | 0.035 | Glutamate (mGluR8) agonist | |||
| 0.016 | 0.013 | 0.016 | Vitamin D receptor agonist | |||
| 0.022 | 0.019 | 0.081 | Protein 30S ribosomal subunit inhibitor | 0.081 0.004 CID_154700035 | CID_154700035 | |
| 0.053 | 0.051 | 0.053 | Leukotriene C antagonist | |||
| 0.09 | 0.089 | 0.128 | Protein-tyrosine phosphatase 1B inhibitor | 0.128 0.057 CID_154700035 | CID_154700035 | |
| 0.052 | 0.05 | 0.052 | Biliverdin reductase inhibitor | |||
| 0.04 | 0.039 | 0.094 | Mannosidase inhibitor | 0.094 0.006 CID_154700035 | CID_154700035 | |
| 0.074 | 0.073 | 0.074 | NMDA receptor antagonist | |||
| 0.214 | 0.214 | 0.625 | Antibacterial | 0.625 0.016 CID_154700035 | CID_154700035 | |
| 0.129 | 0.129 | 0.136 | Heat shock protein 70 antagonist | 0.136 0.093 CID_154700035 | CID_154700035 | |
| 0.08 | 0.081 | 0.1 | Thioredoxin inhibitor | 0.1 0.048 CID_154700035 | CID_154700035 | |
| 0.023 | 0.024 | 0.036 | Vanilloid 2 agonist | 0.036 0.005 CID_154700035 | CID_154700035 | |
| 0.088 | 0.089 | 0.235 | AMP-activated protein kinase stimulant | 0.235 0.008 CID_154700035 | CID_154700035 | |
| 0.049 | 0.051 | 0.058 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.058 0.037 CID_154700035 | CID_154700035 | |
| 0.112 | 0.115 | 0.194 | Diuretic | 0.194 0.046 CID_154700035 | CID_154700035 | |
| 0.034 | 0.066 | 0.12 | Protein 50S ribosomal subunit inhibitor | 0.12 0.009 CID_154700035 | CID_154700035 | |
| 0.007 | 0.045 | 0.021 | Ileal bile acid transport inhibitor | 0.021 0.008 CID_154700035 | CID_154700035 | |
| 0.079 | 0.12 | 0.164 | Alkylator | 0.164 0.04 CID_154700035 | CID_154700035 | |
| 0.063 | 0.106 | 0.185 | Monophenol monooxygenase inhibitor | 0.185 0.037 CID_154700035 | CID_154700035 | |
| 0.099 | 0.145 | 0.129 | Protein-tyrosine phosphatase inhibitor | 0.129 0.102 CID_154700035 | CID_154700035 | |
| 0.014 | 0.061 | 0.053 | Sodium/glucose cotransporter 2 inhibitor | 0.053 0.006 CID_154700035 | CID_154700035 | |
| 0.013 | 0.061 | 0.043 | Arginase inhibitor | 0.043 0.019 CID_154700035 | CID_154700035 | |
| 0.169 | 0.222 | 0.529 | Antithrombotic | 0.529 0.025 CID_154700035 | CID_154700035 | |
| 0.002 | 0.062 | 0.017 | Antibiotic Macrolide-like | 0.017 0.008 CID_154700035 | CID_154700035 | |
| 0.162 | 0.223 | 0.343 | Vasodilator, coronary | 0.343 0.059 CID_154700035 | CID_154700035 | |
| 0.099 | 0.159 | 0.193 | Hexokinase inhibitor | 0.193 0.04 CID_154700035 | CID_154700035 | |
| 0.015 | 0.077 | 0.042 | Sodium/glucose cotransporter inhibitor | 0.042 0.006 CID_154700035 | CID_154700035 | |
| 0.071 | 0.138 | 0.152 | Beta glucuronidase inhibitor | 0.152 0.024 CID_154700035 | CID_154700035 | |
| 0.117 | 0.203 | 0.296 | Spasmolytic | 0.296 0.071 CID_154700035 | CID_154700035 | |
| 0.013 | 0.107 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.017 CID_154700035 | CID_154700035 | |
| 0.104 | 0.203 | 0.218 | Non-steroidal antiinflammatory agent | 0.218 0.058 CID_154700035 | CID_154700035 | |
| 0.02 | 0.134 | 0.08 | Antibiotic Aminoglycoside-like | 0.08 0.004 CID_154700035 | CID_154700035 | |
| 0.029 | 0.148 | 0.085 | Heparanase inhibitor | 0.085 0.005 CID_154700035 | CID_154700035 | |
| 0.014 | 0.141 | 0.042 | Phosphorylase inhibitor | 0.042 0.035 CID_154700035 | CID_154700035 | |
| 0.099 | 0.228 | 0.535 | Free radical scavenger | 0.535 0.013 CID_154700035 | CID_154700035 | |
| 0.076 | 0.213 | 0.195 | Cell wall synthesis inhibitor | 0.195 0.032 CID_154700035 | CID_154700035 | |
| 0.031 | 0.183 | 0.12 | Topoisomerase II alpha inhibitor | 0.12 0.03 CID_154700035 | CID_154700035 | |
| 0.023 | 0.18 | 0.065 | Nitric oxide donor | 0.065 0.04 CID_154700035 | CID_154700035 | |
| 0.068 | 0.291 | 0.363 | Platelet adhesion inhibitor | 0.363 0.017 CID_154700035 | CID_154700035 | |
| 0.069 | 0.309 | 0.136 | DNA repair enzyme inhibitor | 0.136 0.047 CID_154700035 | CID_154700035 | |
| 0.066 | 0.309 | 0.26 | NOS3 expression enhancer | 0.26 0.024 CID_154700035 | CID_154700035 | |
| 0.03 | 0.275 | 0.065 | Adenine nucleotide translocase inhibitor | 0.065 0.021 CID_154700035 | CID_154700035 | |
| 0.025 | 0.279 | 0.199 | Topoisomerase I inhibitor | 0.199 0.027 CID_154700035 | CID_154700035 | |
| 0.017 | 0.283 | 0.075 | Neuraminidase (influenza) inhibitor | 0.075 0.029 CID_154700035 | CID_154700035 | |
| 0.013 | 0.292 | 0.051 | Neuraminidase (Influenza A) inhibitor | 0.051 0.023 CID_154700035 | CID_154700035 | |
| 0.061 | 0.35 | 0.188 | Hemostatic | 0.188 0.038 CID_154700035 | CID_154700035 | |
| 0.01 | 0.313 | 0.065 | Neuraminidase inhibitor | 0.065 0.038 CID_154700035 | CID_154700035 | |
| 0.018 | 0.336 | 0.079 | Glucose-6-phosphate translocase inhibitor | 0.079 0.011 CID_154700035 | CID_154700035 | |
| 0.024 | 0.355 | 0.173 | Topoisomerase II inhibitor | 0.173 0.04 CID_154700035 | CID_154700035 | |
| 0.05 | 0.408 | 0.464 | Insulin secretagoues | 0.464 0.005 CID_154700035 | CID_154700035 | |
| 0.012 | 0.379 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 CID_154700035 | CID_154700035 | |
| 0.036 | 0.429 | 0.195 | Hypolipemic | 0.195 0.098 CID_154700035 | CID_154700035 | |
| 0.015 | 0.57 | 0.082 | Uric acid excretion stimulant | 0.082 0.08 CID_154700035 | CID_154700035 | |
| 0.014 | 0.587 | 0.099 | ATPase (Vacuolar H+) inhibitor | 0.099 0.042 CID_154700035 | CID_154700035 | |
| 0.005 | 0.621 | 0.331 | Selectin antagonist | 0.331 0.004 CID_154700035 | CID_154700035 | |
| 0.013 | 0.666 | 0.248 | Thrombolytic | 0.248 0.034 CID_154700035 | CID_154700035 | |
| 0.009 | 0.803 | 0.162 | Cell adhesion inhibitor | 0.162 0.039 CID_154700035 | CID_154700035 | |
| 0.013 | 0.863 | 0.242 | Immunomodulator | 0.242 0.121 CID_154700035 | CID_154700035 | |
| 0.008 | 0.954 | 0.054 | Factor IXa inhibitor | 0.054 0.032 CID_154700035 | CID_154700035 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |